Coherus BioSciences Inc (CHRS) earnings · rev $42.2M
These earnings events as JSON? API free 100/dayCoherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
This CHRS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CHRS revenue for 2025-12-31 was $42.2M. Net income was $168.0M. Revenue was down 84.2% from 2024-12-31 to 2025-12-31. CHRS currently screens at market cap $223.7M.
When the next CHRS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 84.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full CHRS research stays on the stock page; the tape stays on the quote page.
CHRS earnings FAQ
What are CHRS's latest revenue and net income?
Latest cached Coherus BioSciences Inc (CHRS) revenue for Dec 31, 2025 was $42.2M. Net income was $168.0M. Statements: https://lician.com/financials/chrs
What is CHRS's latest diluted EPS?
Latest cached Coherus BioSciences Inc (CHRS) diluted EPS for Dec 31, 2025 was $1.43.
What period does the latest CHRS earnings print cover?
The latest cached Coherus BioSciences Inc (CHRS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did CHRS revenue change from the prior cached period?
Cached Coherus BioSciences Inc (CHRS) revenue was down 84.2% from $267.0M (Dec 31, 2024) to $42.2M (Dec 31, 2025). Statements: https://lician.com/financials/chrs
Where are CHRS earnings listed?
Cached earnings facts for Coherus BioSciences Inc (CHRS) are listed at https://lician.com/earnings/chrs. Statements: https://lician.com/financials/chrs
Not investment advice.